Idiopathic Juxtafoveal Retinal Telangiectasia

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

1.	Chhablani, Jay: 2 articles (11/2014 - 04/2014)
2.	Narayanan, Raja: 2 articles (11/2014 - 04/2014)
3.	Agarwal, Manisha: 1 article (11/2014)
4.	Mayor, Rahul: 1 article (11/2014)
5.	Singh, Shalini: 1 article (11/2014)
6.	Venkatesh, Ramesh: 1 article (11/2014)
7.	Mithal, Kopal: 1 article (04/2014)
8.	Rao, Harsha: 1 article (04/2014)
9.	Ambresin, Aude: 1 article (11/2009)
10.	Konstantinidis, Lazaros: 1 article (11/2009)

Drugs and Important Biological Agents (IBA) related to Idiopathic Juxtafoveal Retinal Telangiectasia:

1.	Fluorescein (Funduscein)FDA LinkGeneric 11/01/2014 - "Fluorescein angiography versus spectral domain optical coherence tomography in idiopathic juxtafoveal retinal telangiectasia." 11/01/2014 - "Diagnosis of subretinal neovascularization associated with idiopathic juxtafoveal retinal telangiectasia - fluorescein angiography versus spectral-domain optical coherence tomography - can we choose?" 04/01/2014 - "To compare ability of fluorescein angiography (FFA) and spectral-domain optical coherence tomography (SD-OCT) to diagnose subretinal neovascularization (SRNV) secondary to idiopathic juxtafoveal retinal telangiectasia (IJRT) type 2A. " 04/01/2014 - "Diagnosis of subretinal neovascularization associated with idiopathic juxtafoveal retinal telangiectasia - fluorescein angiography versus spectral-domain optical coherence tomography."
2.	Retinaldehyde (Retinal)IBA 11/01/2008 - "Idiopathic juxtafoveal retinal telangiectasia (IJRT) is a rare retinal condition that can be detected even in asymptomatic patients. "
3.	Ranibizumab (Lucentis)FDA Link 11/01/2009 - "Intravitreal ranibizumab as primary treatment for neovascular membrane associated with idiopathic juxtafoveal retinal telangiectasia."